Risks factors for highly unstable response to oral anticoagulation: a case‐control study
Open Access
- 21 March 2005
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 129 (1) , 72-78
- https://doi.org/10.1111/j.1365-2141.2005.05417.x
Abstract
The factors associated with persistent instability of oral anticoagulant treatment (OAT) were investigated in a case‐control study. The most unstable patients from 35 Italian anticoagulation clinics were matched with stable controls, for gender, age and OAT indication. Socio‐demographic data, medical history, dietary and life habits, cytochrome P450 CYP2C9 variants, blood cell count, liver and renal functions were investigated. An ‘Abbreviated Mental Test’ (AMT) and a questionnaire to assess patient compliance to, and comprehension of, OAT indications and mechanisms were administered. An International Normalized Ratio (INR) above 4·5 was more frequently found in cases (n = 77) than controls (n = 80) (12·3% vs. 0·4%; P < 0·0001). The odds ratio for instability was significantly higher for: people who worked versus pensioners, acenocoumarol versus warfarin, and an insufficient score in the AMT and/or in the questionnaire. Cytochrome P450 CYP2C9 variants *1/*3 or *2/*3 or *3/*3 were more frequent among cases than controls (29·9% vs.15·0%; P = 0·042). No differences were observed as regards the other variables. In conclusion, we found that high intra‐individual variability in OAT control was multifactorial, but poor OAT comprehension was prevalent.Keywords
This publication has 21 references indexed in Scilit:
- Relationship Between Patients’ Warfarin Knowledge and Anticoagulation ControlAnnals of Pharmacotherapy, 2003
- Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumonThrombosis and Haemostasis, 2003
- The Frequency and Effects of Cytochrome P450 (CYP) 2C9 Polymorphisms in Patients Receiving WarfarinJournal of the American College of Surgeons, 2002
- Prevalence and Quality of Warfarin Use for Patients With Atrial Fibrillation in the Long-term Care SettingArchives of internal medicine (1960), 2001
- A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving WarfarinAnnals of Internal Medicine, 2000
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complicationsThe Lancet, 1999
- Genetic analysis of CYP2C9 polymorphism in a Japanese populationPharmacogenetics, 1997
- Assessment of mental ability in elderly anticoagulated patientsBlood Coagulation & Fibrinolysis, 1997
- Atrial fibrillation and stroke prevention with warfarin in the long-term care settingArchives of internal medicine (1960), 1997
- Aging and the Anticoagulant Response to Warfarin TherapyAnnals of Internal Medicine, 1992